MREO logo

Mereo BioPharma Group plc

MREO
Healthcare|Biotechnology|GB
$0.28
+0.00 (+0.93%)
DCF Value
$0.26
Tangible Book / Share
$0.18
Cash / Share
$0.19
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (2)

Trials past primary completion date but still active — data readout may be imminent.

Oct 2025
P2P3
Setrusumab vs Placebo for Osteogenesis Imperfecta
NCT05125809
Apr 2025
P2
EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer
NCT05715216

Recent Press Releases

Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
Aug 11, 2026 · GlobeNewsWire
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
Aug 11, 2026 · PRNewsWire

SEC Filings (60)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 28, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 19, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 14, 20268-KMaterial eventDocumentIndex
May 12, 20268-K/AMaterial eventDocumentIndex
May 12, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
Apr 9, 2026ARSAnnual report to holdersDocumentIndex
Apr 9, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 27, 2026PRE 14AProxy / shareholder voteDocumentIndex
Mar 27, 20268-KMaterial eventDocumentIndex
Mar 19, 202610-KAnnual reportDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 2, 2026S-8Employee stock planDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Jan 9, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 6, 2026SC 13GPassive 5%+ stakeDocumentIndex
Dec 29, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 10, 20258-KMaterial eventDocumentIndex
Nov 10, 202510-QQuarterly reportDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 12, 202510-QQuarterly reportDocumentIndex
Aug 12, 20258-KMaterial eventDocumentIndex
Jul 10, 20258-KMaterial eventDocumentIndex
Jun 11, 2025SC 13GPassive 5%+ stakeDocumentIndex
May 15, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 20258-KMaterial eventDocumentIndex